Tag: LDAA therapy
Azathioprine and Allopurinol: How the Combination Prevents Toxic Metabolite Buildup
LDAA therapy combines low-dose azathioprine with allopurinol to redirect toxic metabolite buildup in IBD patients. It’s effective for those with high TPMT activity and liver damage from standard therapy - but only with strict dosing and monitoring.
Read more